Truist Financial’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,129
Closed -$258K 2584
2022
Q3
$258K Hold
20,129
﹤0.01% 2168
2022
Q2
$209K Hold
20,129
﹤0.01% 2426
2022
Q1
$274K Hold
20,129
﹤0.01% 2373
2021
Q4
$266K Sell
20,129
-1,571
-7% -$19.8K ﹤0.01% 2438
2021
Q3
$172K Sell
21,700
-1,694
-7% -$11.7K ﹤0.01% 2591
2021
Q2
$161K Hold
23,394
﹤0.01% 2618
2021
Q1
$143K Hold
23,394
﹤0.01% 2549
2020
Q4
$73K Buy
23,394
+1,300
+6% +$4.53K ﹤0.01% 2489
2020
Q3
$56K Hold
22,094
﹤0.01% 2387
2020
Q2
$51K Hold
22,094
﹤0.01% 2333
2020
Q1
$23K Sell
22,094
-10,250
-32% -$34.6K ﹤0.01% 2325
2019
Q4
$118K Buy
+32,344
New +$112K ﹤0.01% 2409

Other funds holding CLMT

Truist Financial's CLMT Position: Q4 2022 in Review

Truist Financial sold out of Calumet Specialty Products (CLMT) in Q4 2022, closing a stake of 20,129 shares — an estimated $258K sold.

Truist Financial first reported a position in CLMT in Q4 2019 and held it in 12 quarters. The position peaked at $274K in Q1 2022. 72 funds tracked by Wall St. Rank hold CLMT as of Q4 2022.

  • Truist Financial reported no remaining Calumet Specialty Products position as of Q4 2022 after selling out during the quarter.
  • Truist Financial sold 20,129 Calumet Specialty Products shares in Q4 2022, an estimated $258K.
  • Truist Financial first reported a position in Calumet Specialty Products in Q4 2019 and held it in 12 quarters.
  • Truist Financial's Calumet Specialty Products position peaked at $274K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2022.

Based on Truist Financial's 13F filing for Q4 2022, filed 17 Feb 2023.